32. Saldias, M. S. Burkholderia cenocepacia O antigen lipopolysaccharide prevents phagocytosis by macrophages and adhesion to epithelial cells / M. S. Saldias, X. Ortega, M. A. Valvano // J. Med. Microbiol. - 2009. - Vol. 58, Pt. 12. - P. 1542-1548.
33. Schobert, M. Contribution of oxygen-limiting conditions to persistent infection of Pseudomonas aeruginosa / M. Schobert, P. Tielen // Future Microbiol. - 2010. - Vol. 5, № 4. - P. 603-621.
34. Silva, I. N. Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence / I. N. Silva, A. S. Ferreira, J. D. Becker, J. E. Zlosnik, D. P. Speert, J. He, D. Mil-Homens, L. M. Moreira // Microbiology. - 2011. - Vol. 157, Pt. 11. - P. 3124-3137.
35. Toguchi, A. Genetics of swarming motility in Salmonella enterica serovar typhimurium: critical role for lipopolysaccharide / A. Toguchi, M. Siano, M. Burkart, R. M. Harshey // J. Bacteriol. - 2000. - Vol. 182, № 22. - P. 6308-6321.
36. Vinion-Dubiel, A. D. Lipopolysaccharide of Burkholderia cepacia complex / A. D. Vinion-Dubiel, J. B. Goldberg // J. Endotoxin Res. - 2003. - Vol. 9, № 4. - P. 201-213.
37. Weaver, V. B. Burkholderia spp. alter Pseudomonas aeruginosa physiology through iron sequestration // V. B. Weaver, R. Kolter // J. Bacteriol. - 2004. - Vol. 186, № 8. - P. 2376-2384.
38. Winstanley, C. Pseudomonas aeruginosa evolutionary adaptation and diversification in cystic fibrosis chronic lung infections / C. Winstanley, S. O'Brien, M. A. Brockhurst // Trends Microbiol. - 2016. - Vol. 24, № 5 - P. 327-337.
Referenses
1. Afanas'eva M. V., Amelina E. L., Chernyak A. V., Butyugina I. N., Gracheva O. Yu., Shaginyan I. A., Polikarpova S. V., Chernukha M. Yu., Avetisyan L. R., Kondrat'eva E. I., Aver'yanov A. V., Krasovskiy S. A. Vyzhivaemost' vzroslykh bol'nykh mukovistsidozom s khronicheskoy infektsiey respiratornogo trakta, obuslovlennogo mikroorganizmami Burkholderia cepacia complex [Survival of adult cystic fibrosis patients with chronic respiratory tract infection caused by Burkholderia cepacia complex microorganisms]. Prakticheskaya pul'monologiya. [Practical pulmonology], 2018, no. 1, pp. 60-64.
2. Voronina O. L., Chernukha M. Yu., Shaginyan I. A., Kunda M. S., Avetisyan L. R., Orlova A. A., Lunin V. G., Avakyan L. V., Kapranov N. I., Amelina E. L., Chuchalin A. G., Gintsburg A. L. Kharakteristika genoti- pov shtammov Burkholderia cepacia complex, vydelennykh ot bol'nykh v statsionarakh Rossiyskoy Federatsii [Characteristics of genotypes of Burkholderia cepacia complex strains isolated from patients in hospitals of the Russian Federation]. Molekulyarnaya genetika, mikrobiologiya i virusologiya [Molecular genetics, Microbiology and Virology.], 2013, no. 2, pp. 22-30.
3. Krasovskiy S. A., Amelina E. L., Kashirskaya N. Yu., Voronkova A. Yu., Zonenko O. G. Dinamika poka- zateley natsional'nogo registra bol'nykh mukovistsidozom za 2011-2017 goda [Dynamics of indicators of the national register of patients with cystic fibrosis for 2011-2017]. Sibirskoe meditsinskoe obozrenie [Siberian Medical Review], 2019, no. 2, pp. 14-18.
4. Krasovskiy S. A., Afanas'eva M. V., Amelina E. L., Chernyak A. V., Shaginyan I. A., Polikarpova S. V., Avetisyan L. R., Chernukha M. Yu., Zonenko O. G., Butyugina I. N. Infitsirovanie respiratornogo trakta mikroor- ganizmami B. cepacia complex kak neblagopriyatnyy prognosticheskiy faktor u bol'nykh mukovistsidozom [Infection of the respiratory tract by B. cepacia complex microorganisms as an unfavorable prognostic factor in patients with cystic fibrosis]. Sibirskoe meditsinskoe obozrenie. [Siberian Medical Review], 2019, no. 2, pp. 89-94.
5. Sergienko D. F., Bashkina O. A., Galimzyanov Kh. M. Osobennosti klinicheskogo techeniya i mekhanizmy immunnoy regulyatsii u detey s mukovistsidozom [Features of the clinical course and mechanisms of immune regulation in children with mucoviscididosis]. Astrakhan', Astrakhan State Medical Academy, 2010, 138 р.
6. Berry M. C., McGhee G. C., Zhao Y., Sundin G. W. Effect of a waaL mutation on lipopolysaccharide composition, oxidative stress survival, and virulence in Erwinia amylovora. FEMS Microbiol. Lett., 2009, vol. 291, no. 1, pp. 80-87.
7. Bowden S. D., Hale N., Chung J. C. S., Hodgkinson J. T., Spring D. R., Welch M. Surface swarming motility by Pectobacterium atrosepticum is a latent phenotype that requires O antigen and is regulated by quorum sensing. Microbiology, 2013, vol. 159, pp. 2375-2385.
8. Coutinho C. P., De Carvalho C. C., Madeira A., Pinto-De-Oliveira A., Sa-Correia I. Burkholderia cenoce- pacia phenotypic clonal variation during a 3.5-year colonization in the lungs of a cystic fibrosis patient. Infect. Immun., 2011, vol. 79, no. 7, pp. 2950-2960.
9. Coutinho C. P., dos Santos S. C., Madeira A., Mira N. P., Moreira A. S., Sa-Correia I. Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations. Front Cell Infect. Microbiol., 2011, vol. 1, pp. 1-11.
10. Cullen L., McClean S. Bacterial adaptation during chronic respiratory infections. Pathogens, 2015, vol. 4, no. 1, pp. 66-89.
11. Cunha M. V., Leitдo J. H., Mahenthiralingam E., Vandamme P., Lito L., Barreto C., Salgado M. J., Sa-Correia I. Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study. J. Clin. Microbiol., 2003, vol. 41, no. 9, pp. 4113-4120.
12. Cunha M. V., Sousa S. A., Leitдo J. H., Moreira L. M., Videira P. A., Sa-Correia I. Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections. J. Clin. Microbiol., 2004, vol. 42, no. 7, pp. 3052-3058.
13. Dцring G., Parameswaran I. G., Murphy T. F. Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease. FEMS Microbiol. Rev., 2011, vol. 35, no. 1, pp. 124-146.
14. Faure E. Kwong K., Nguyen D. Pseudomonas aeruginosa in chronic lung infections: how to adapt within the host? Front. Immunol., 2018, vol. 9, p. 2416.
15. Harrison F. Microbial ecology of the cystic fibrosis lung. Microbiology, 2007, vol. 153, pp. 917-923.
16. Hassan A. A., Maldonado R. F., dos Santos S. C., Di Lorenzo F., Silipo A., Coutinho C. P., Cooper V. S., Molinaro A., Valvano M. A., Sa-Correia I. Structure of O-antigen and hybrid biosynthetic locus in Burkholderia cenocepacia clonal variants recovered from a cystic fibrosis patient. Front. Microbiol., 2017, vol. 8, p. 1027.
17. Hoboth C., Hoffmann R., Eichner A., Henke C., Schmoldt S., Imhof A., Heesemann J., Hogardt M. Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. J. Infect. Dis., 2009, vol. 200, no. 1, pp. 118-130.
18. Hogardt M. Heesemann J. Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. Int. J. Med. Microbiol., 2010, vol. 300, no. 8, pp. 557-562.
19. King J. D., Kocincova D., Westman E. L., Lam J. S. Review: Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa. Innate Immunity, 2009, vol. 15, no. 5, pp. 261-312.
20. Kцhler S., Ekaza E., Paquet J. Y., Walravens K., Teyssier J., Godfroid J., Liautard J. P. Induction of dnaK through its native heat shock promoter is necessary for intramacrophagic replication of Brucella suis. Infect Immun., 2002, vol. 70, no. 3, pp. 1631-1634.
21. Kotrange S., Kopp B., Akhter A., Abdelaziz D., Abu Khweek A., Caution K., Abdulrahman B., Wewers M. D., McCoy K., Marsh C., Loutet S. A., Ortega X., Valvano M. A., Amer A. O. Burkholderia cenocepacia O polysaccharide chain contributes to caspase-1-dependent IL-1beta production in macrophages. J. Leukoc. Biol., 2011, vol. 89, no. 3, pp. 481-488.
22. Lieberman T. D., Michel J. B., Aingaran M., Potter-Bynoe G., Roux D., Davis M. R. Jr., Skurnik D., Leiby N., LiPuma J. J., Goldberg J. B., McAdam A. J., Priebe G. P., Kishony R. Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat. Genetics, 2011, vol. 43, no. 12, pp. 1275-1280.
23. Lieberman T. D., Flett K. B., Yelin I., Martin T. R., McAdam A. J., Priebe G. P., Kishony R. Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures. Nat. Genetics, 2014, vol. 46, no. 1, pp. 82-87.
24. Lorenzo F. D., Sturiale L., Palmigiano A., Lembo-Fazio L., Paciello I., Coutinho C. P., Sa-Correia I., Bernardini M., Lanzetta R., Garozzo D., Silipo A., Molinaro A. Chemistry and biology of the potent endotoxin from a Burkholderia dolosa clinical isolate from a cystic fibrosis patient. Chem. Biochem., 2013. vol. 14, no. 9, pp. 1105-1115.
25. Madeira A., Santos P. M., Coutinho C. P., Pinto-de-Oliveira A., Sa-Correia I. Quantitative proteomics (2-D DIGE) reveals molecular strategies employed by Burkholderia cenocepacia to adapt to the airways of cystic fibrosis patients under antimicrobial therapy. Proteomics, 2011, vol. 11, no. 7, pp. 1313-1328.
26. Maldonado R. F., Sa-Correia I., Valvano M. A. Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. FEMS Microbiol. Rev., 2016, vol. 40, no. 4, pp. 480-493.
27. Malinvemi J. C., Werner J., Kim S., Sklar J. G., Kahne D., Misra R., Silhavy T. J. YfiO stabilizes the YaeT complex and is essential for outer membrane protein assembly in Escherichia coli. Mol. Microbiol., 2006, vol. 61, no. 1, pp. 151-164.
28. Moreira A. S., Coutinho C. P., Azevedo P., Lito L., Melo-Cristino J., Sa-Correia I. Burkholderia dolosa phenotypic variation during the decline in lung function of a cystic fibrosis patient during 5.5 years of chronic colonization. J. Med. Microbiol., 2014, vol. 63, pt. 4, pp. 594-601.
29. Murray G. L., Attridge S. R., Morona R. Regulation of Salmonella typhimurium lipopolysaccharide O antigen chain length is required for virulence; identification of FepE as a second Wzz. Mol. Microbiol., 2003, vol. 47, № 5, pp. 1395-1406.
30. Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev., 2003, vol. 67, no. 4, pp. 593-656.
31. Pier G. B. Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity. Int. J. Med. Microbiol., 2007, vol. 297, no. 5, pp. 277-295.
32. Saldias M. S., Ortega X., ValvanoM. A. Burkholderia cenocepacia O antigen lipopolysaccharide prevents phagocytosis by macrophages and adhesion to epithelial cells. J. Med. Microbiol., 2009, vol. 58, pt. 12, pp. 1542-1548.
33. Schobert M., Tielen P. Contribution of oxygen-limiting conditions to persistent infection of Pseudomonas aeruginosa. Future Microbiol., 2010, vol. 5, no. 4, pp. 603-621.
34. Silva I. N., Ferreira A. S., Becker J. D., Zlosnik J. E., Speert D. P., He J., Mil-Homens D., Moreira L. M. Mucoidmorphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence. Microbiology, 2011, vol. 157, pt. 11, pp. 3124-3137.
35. Toguchi A., Siano M., Burkart M., Harshey R. M. Genetics of swarming motility in Salmonella enterica serovar typhimurium: critical role for lipopolysaccharide. J. Bacteriol., 2000, vol. 182, no. 22, pp. 6308-6321.
36. Vinion-Dubiel A. D., Goldberg J. B. Lipopolysaccharide of Burkholderia cepacia complex. J. Endotoxin Res., 2003, vol. 9, no. 4, pp. 201-213.
37. Weaver V. B., Kolter R. Burkholderia spp. Alter Pseudomonas aeruginosa physiology through iron sequestration. J. Bacteriol., 2004, vol. 186, no. 8, pp. 2376-2384.
38. Winstanley C., O'Brien S., Brockhurst M. A. Pseudomonas aeruginosa evolutionary adaptation and diversification in cystic fibrosis chronic lung infections. Trends Microbiol., 2016, vol. 24, no. 5, pp. 327-337.